Загрузка...

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?

Late-onset Alzheimer’s disease (AD) is clinically characterized by a progressive decline of memory and other cognitive functions leading to the loss of the ability to perform everyday activities. Only a few drugs have been approved to treat AD dementia over the past century since the first AD patien...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomolecules
Главные авторы: Jasiecki, Jacek, Wasąg, Bartosz
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6843418/
https://ncbi.nlm.nih.gov/pubmed/31601022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100592
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!